Budd–Chiari Syndrome Management: Controversies and Open Issues-Reference-Cited by-同舟云学术

Budd–Chiari Syndrome Management: Controversies and Open Issues

Published:2022-11-03 Issue:11 Volume:12 Page:2670
ISSN:2075-4418
Container-title:Diagnostics
language:en
Short-container-title:Diagnostics

Author:

Mancuso Andrea^ORCID

Abstract

Budd–Chiari Syndrome (BCS) is due to thrombosis of hepatic veins (HVs), inferior vena cava (IVC) or both, leading to impaired hepatic venous outflow [...]

Publisher

MDPI AG

Subject

Clinical Biochemistry

Link

https://www.mdpi.com/2075-4418/12/11/2670/pdf

Reference76 articles.

1. Timing of TIPS in Budd Chiari syndrome: An Italian Hepatologist’s perspective;Mancuso;J. Transl. Int. Med.,2017

2. Vascular disorders of the liver;DeLeve;Hepatology,2009

3. Budd-Chiari syndrome management: Lights and shadows;Mancuso;World J. Hepatol.,2011

4. An update on management of Budd-Chiari syndrome;Mancuso;Ann. Hepatol.,2014

5. EASL clinical practice guidelines: Vascular diseases of the liver;Garcia-Pagán;J. Hepatol.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare presentation of recurrent ovarian carcinoma with secondary Budd–Chiari syndrome: a case report;Egyptian Journal of Radiology and Nuclear Medicine;2024-07-01

2. Fibrosis Progression in Patients with Budd–Chiari Syndrome and Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Long-Term Study Using Transient Elastography;Diagnostics;2024-02-05

3. Radiobioinformatics: A novel bridge between basic research and clinical practice for clinical decision support in diffuse liver diseases;iRADIOLOGY;2023-06